• Home Dutch
  •  EN 
  • Employee login

Quality of prescribing: patient specific indicators that predict better outcomes in diabetes patients

Title:   Quality of prescribing: patient specific indicators that predict better outcomes in diabetes patients
Investigator(s):  Kirsten Smits
Supervisor:  Grigory Sidorenkov
Promotores: Petra Denig, Henk Bilo, Gerjan Navis
Summary:  The current quality indicator sets for diabetes care lacks good indicators for measuring the quality of medication treatment. The aim of this project is to develop a set of valid indicators to be used for evaluating and improving chronic medication treatment in patients with type 2 diabetes. These novel prescribing quality indicators should (1) capture the quality of chronic treatment over time, (2) take into account differentiation for patient characteristics, (3) predict better patient outcomes, and (4) be measurable using routinely collected data from primary care.
The project consists of three phases needed for development and implementation of valid quality indicators. In phase 1, the indicators will be defined and judged on reflecting evidence and guideline recommendations by an expert panel, including patient representatives. The operational and statistical validity will be tested using routinely collected healthcare data for >85.000 diabetes patients. In phase 2, the selected indicators will be tested for predictive validity on a composite outcome of diabetes-related complications and death in >20.000 patients. In subsets of around 1300 patients, the predictive validity on quality of life will be assessed as well. The prescribing quality indicators that show to be associated with either clinical or quality of life outcomes, are considered valid for educational and benchmarking purposes in actual practice. In phase 3, a plan will be made in cooperation with national authorities responsible for measuring and improving quality of care to set off the implementation and evaluation of using this final set of prescribing quality indicators in practice.
Financing:  ZonMw
Start:  1-4-2014
End: 1-10-2016


The use of a multiple parameter response efficacy score to predict the effect of a drug on hard renal and cardiovascular
Diabetes Mellitus Treatment for Renal Insufficiency Consortium (DIAMETRIC) database 
System biology approach for discovery of biomarkers of renal disease progressioni in diabetes (SysKid)
PROVALID – prospective multinational cohort study in patients with type 2 diabetes treated in primary care
Vitamin-D deficiency as a risk marker for renal and CV complications in the general population
A novel approach of personalized medicine: considering multiple effects of a single drug
Optimal hard endpoints in clinical trials of renal disease progression
Albuminuria as surrogate endpoint in clinical trials
Individual therapy response to a sodium-glucose transport inhibitor
Involving patients in the assessment and evaluation of medication treatment
Groningen Initiative to Analyse Type-2 diabetes Treatment ( GIANTT )
The role of medication adherence in predicting treatment response and estimating cost-effectiveness of statin treatment
Pharmacogenetics and response to treatment of oral antidiabetics
Quality of prescribing: patient specific indicators that predict better outcomes in diabetes patients
Quality assessment of pharmacotherapy in patients with chronic kidney disease
Cost effectiveness of ACEi and ARBs on renal failure in diabetes patients
Drug information and risk communication in Africa
Regulatory Science Projects